Magnus Gisslen Selected Research

Tumor Necrosis Factor Ligand Superfamily Member 14

1/2022	Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study.
1/2019	Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate.
6/2007	Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magnus Gisslen Research Topics

Disease

9	Inflammation (Inflammations) 01/2022 - 09/2011
7	Infections 02/2022 - 11/2005
7	HIV Infections (HIV Infection) 01/2022 - 11/2005
5	Central Nervous System Infections (Central Nervous System Infection) 01/2019 - 06/2010
5	AIDS Dementia Complex 03/2011 - 05/2004
4	COVID-19 02/2022 - 12/2020
3	Dementia (Dementias) 01/2021 - 03/2011
3	Acquired Immunodeficiency Syndrome (AIDS) 12/2019 - 03/2007
3	Encephalitis (Encephalitis, Rasmussen) 06/2010 - 12/2004
2	Neuroinflammatory Diseases 01/2022 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 03/2007
2	Persistent Infection 09/2014 - 09/2011
2	Central Nervous System Diseases (CNS Diseases) 12/2013 - 12/2004
2	Brain Injuries (Brain Injury) 06/2010 - 03/2007
1	Myocardial Infarction 02/2022
1	Necrosis 02/2022
1	Confusion (Bewilderment) 01/2022
1	Atrophy 01/2022
1	Ataxia (Dyssynergia) 01/2022
1	Lethargy 01/2022
1	Heart Failure 01/2021
1	Heart Injuries 01/2021
1	Disease Progression 01/2021
1	Neurobehavioral Manifestations 01/2021
1	Cognitive Dysfunction 01/2021
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 07/2019
1	Neurocognitive Disorders (Clerambault Syndrome) 12/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2014
1	Cryptococcal Meningitis 06/2010
1	Opportunistic Infections (Opportunistic Infection) 06/2010
1	Retroviridae Infections (Infection, Retrovirus) 11/2005
1	Leukoencephalopathies 12/2004
1	Neurologic Manifestations (Neurological Manifestations) 05/2004

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2007
8	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2005
7	NeopterinIBA 01/2022 - 03/2007
3	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2022 - 06/2007
2	Immunoglobulin G (IgG)IBA 02/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2005
2	ChemokinesIBA 09/2011 - 11/2005
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2004 - 05/2004
1	Troponin T (Troponin T1)IBA 02/2022
1	Trinitrotoluene (TNT)IBA 02/2022
1	Troponin IIBA 02/2022
1	TroponinIBA 02/2022
1	AntibodiesIBA 02/2022
1	AutoantibodiesIBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Disulfiram (Antabuse)FDA Link 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	chloroquine diphosphate FDA LinkGeneric 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2014
1	Biological ProductsIBA 12/2013
1	ProteomeIBA 12/2013
1	AlbuminsIBA 09/2011
1	Serum AlbuminIBA 09/2011
1	Pharmaceutical PreparationsIBA 03/2007
1	Antiviral Agents (Antivirals)IBA 03/2007
1	Chemotactic FactorsIBA 11/2005
1	Interferon-gamma (Interferon, gamma)IBA 11/2005
1	Plasminogen Activators (Plasminogen Activator)IBA 12/2004
1	HIV Core Protein p24IBA 12/2004

Therapy/Procedure

4	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 06/2010
3	Art Therapy 01/2022 - 06/2015
2	Therapeutics 12/2020 - 03/2007
1	Critical Care (Surgical Intensive Care) 12/2020